Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dcha-hf Cpd
2. Hyperforin Dicyclohexylammonium
1. 238074-03-8
2. Hyperforin-dcha
3. Hyperforin . Dcha
4. Hyperforin Dcha
5. N-cyclohexylcyclohexanamine;(1r,5r,7s,8r)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione
6. Hyperforin (dicyclohexylammonium Salt)
7. Hyperforin (dicyclohexylammonium) Salt
8. Chembl397036
9. Schembl7622838
10. Dtxsid30677360
11. Mfcd04000098
12. Akos025294968
13. Hy-116330a
14. Hyperforin / Adhyperforin, Hplc Grade
15. Cs-0110266
16. J-015220
17. Hyperforin (dicyclohexylammonium) Salt, Analytical Standard
18. (1r,5r,7s,8r)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione--n-cyclohexylcyclohexanamine (1/1)
| Molecular Weight | 718.1 g/mol |
|---|---|
| Molecular Formula | C47H75NO4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 13 |
| Exact Mass | 717.56960987 g/mol |
| Monoisotopic Mass | 717.56960987 g/mol |
| Topological Polar Surface Area | 83.5 Ų |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1260 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Hyperforin-Dcha API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyperforin-Dcha manufacturer or Hyperforin-Dcha supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyperforin-Dcha manufacturer or Hyperforin-Dcha supplier.
PharmaCompass also assists you with knowing the Hyperforin-Dcha API Price utilized in the formulation of products. Hyperforin-Dcha API Price is not always fixed or binding as the Hyperforin-Dcha Price is obtained through a variety of data sources. The Hyperforin-Dcha Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hyperforin DCHA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyperforin DCHA, including repackagers and relabelers. The FDA regulates Hyperforin DCHA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyperforin DCHA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hyperforin DCHA supplier is an individual or a company that provides Hyperforin DCHA active pharmaceutical ingredient (API) or Hyperforin DCHA finished formulations upon request. The Hyperforin DCHA suppliers may include Hyperforin DCHA API manufacturers, exporters, distributors and traders.
Hyperforin DCHA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hyperforin DCHA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hyperforin DCHA GMP manufacturer or Hyperforin DCHA GMP API supplier for your needs.
A Hyperforin DCHA CoA (Certificate of Analysis) is a formal document that attests to Hyperforin DCHA's compliance with Hyperforin DCHA specifications and serves as a tool for batch-level quality control.
Hyperforin DCHA CoA mostly includes findings from lab analyses of a specific batch. For each Hyperforin DCHA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hyperforin DCHA may be tested according to a variety of international standards, such as European Pharmacopoeia (Hyperforin DCHA EP), Hyperforin DCHA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hyperforin DCHA USP).
